Latest & Updates

  • Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients with Advanced Solid Tumors, Demonstrating Single-Agent Activity. RTX-240 Generated Partial Responses in Metastatic Anal Cancer…

  • As the meteoric rise of bitcoin and other cryptocurrencies continues at pace, investment banks are now getting in on the action. For Goldman Sachs, it is a return to a…

  • Online broker eToro has agreed to go public at a $10.4bn valuation after merging with a listed blank cheque company, as the investment platform seeks to capitalise on the recent…

  • Oil futures fell Tuesday, with analysts noting that nearby futures on U.S. benchmark crude have slumped below later-dated contracts, reflecting concerns over a buildup in inventories after last month’s Texas…

  • Lord Myners, the former City minister, has taken aim at the UK financial regulator for failing to spot red flags at Greensill Capital, the embattled supply chain finance firm which…

  • Domestic equities gave up initial gains and traded flat towards the final hours of the day despite favourable cues from global equities. Image: Reuters BSE Sensex and Nifty 50 settled…